Pharmalink
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the CUETO Group (NCT05864599) | Pharmalink | 2023-06-16 |
Track Pharmalink automatically
Every clearance here is in the API, with alerts when new ones post.